Monika E Hegi (Monika Hegi)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 21

Top Venues

Neuro-oncology

Cell death & disease

Nature cancer

The Journal of neuroscience : the official journal of the Society for Neuroscience

Lausanne University Hospital & University of Lausanne

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Lausanne University Hospital & University of Lausanne Jan 01 1998

Switzerland

Prof, PhD :: Clinical Neurosciences

Publications

Monika E Hegi, Felix B Oppong, James R Perry, Wolfgang Wick, Roger Henriksson, Norman J Laperriere, Thierry Gorlia, Annika Malmström, Michael Weller, null null, null null, null null, null null
No benefit from TMZ treatment in GB with truly unmethylated MGMT promoter: Reanalysis of the CE.6 and the pooled Nordic/NOA-08 trials in elderly GB patients. Neuro-oncology (2024)
Monika E Hegi, Felix B Oppong, James R Perry, Wolfgang Wick, Roger Henriksson, Norman J Laperriere, Thierry Gorlia, Annika Malmström, Michael Weller, null null, null null, null null, null null
No benefit from TMZ treatment in GB with truly unmethylated MGMT promoter: Reanalysis of the CE.6 and the pooled Nordic/NOA-08 trials in elderly GB patients. Neuro-oncology (2024)
Thi Tham Nguyen, Premnath Rajakannu, Minh Diêu Thanh Pham, Leo Weman, Alexander Jucht, Michelle C Buri, Kristof Van Dommelen, Monika E Hegi
Epigenetic silencing of HTATIP2 in glioblastoma contributes to treatment resistance by enhancing nuclear translocation of the DNA-repair protein N-methylpurine DNA glycosylase (MPG). Molecular oncology (2023)
Felix Sahm, Sebastian Brandner, Luca Bertero, David Capper, Pim J French, Dominique Figarella Branger, Felice Giangaspero, Christine Haberler, Monika E Hegi, Bjarne Winther Kristensen, Kathreena M Kurian, Matthias Preusser, Bastiaan B J Tops, Martin J Van Den Bent, Wolfgang Wick, Guido Reifenberger, Pieter Wesseling
Molecular diagnostic tools for the World Health Organization (WHO) 2021 classification of gliomas, glioneuronal and neuronal tumors; an EANO guideline. Neuro-oncology (2023)
Vladimir Wischnewski, Roeltje R Maas, Paola Guerrero Aruffo, Klara Soukup, Giovanni Galletti, Mara Kornete, Sabine Galland, Nadine Zangger, Johanna Lilja, Pratyaksha Wirapati, Joao Lourenco, Alice Scarpa, Roy T Daniel, Andreas F Hottinger, Jean-Philippe Brouland, Agnese Losurdo, Emanuele Voulaz, Marco Alloisio, Monika E Hegi, Enrico Lugli, Johanna A Joyce
Phenotypic diversity of T cells in human primary and metastatic brain tumors revealed by multiomic interrogation. Nature cancer (2023)
Sylvia C Kurz, Anja Stammberger, Steffen K Rosahl, Lauren E Abrey, Nathalie L Albert, Louisa V Baumgarten, Bernhard Meyer, Anca-Ligia Grosu, Verena Leidgens, Anna Cecilia Lawson McLean, Mirjam Renovanz, Julia Schwarzenberger, Lisa Sevenich, Tadeja Urbanic Purkart, Stephanie E Combs, Ghazaleh Tabatabai, Monika E Hegi, Martha Nowosielski
Towards more Diversity in Neuro-oncology Leadership-the DivINe Initiative. Neuro-oncology (2023)
Alessandro Tancredi, Olga Gusyatiner, Pierre Bady, Michelle Claudine Buri, Rémy Lomazzi, Davide Chiesi, Mahmoud Messerer, Monika E Hegi
BET protein inhibition sensitizes glioblastoma cells to temozolomide treatment by attenuating MGMT expression. Cell death & disease 13 (12) (2022)
Lea Beltzig, Christian Schwarzenbach, Petra Leukel, Katrin B M Frauenknecht, Clemens Sommer, Alessandro Tancredi, Monika E Hegi, Markus Christmann, Bernd Kaina
Senescence Is the Main Trait Induced by Temozolomide in Glioblastoma Cells. Cancers 14 (9) (2022)
Alessandro Tancredi, Olga Gusyatiner, Pierre Bady, Michelle Claudine Buri, Rémy Lomazzi, Davide Chiesi, Mahmoud Messerer, Monika E Hegi
BET protein inhibition sensitizes glioblastoma cells to temozolomide treatment by attenuating MGMT expression. Cell death & disease 13 (12) (2022)
Alessandro Tancredi, Olga Gusyatiner, Pierre Bady, Michelle Claudine Buri, Rémy Lomazzi, Davide Chiesi, Mahmoud Messerer, Monika E Hegi
BET protein inhibition sensitizes glioblastoma cells to temozolomide treatment by attenuating MGMT expression. Cell death & disease 13 (12) (2022)
Alessandro Tancredi, Olga Gusyatiner, Pierre Bady, Michelle Claudine Buri, Rémy Lomazzi, Davide Chiesi, Mahmoud Messerer, Monika E Hegi
BET protein inhibition sensitizes glioblastoma cells to temozolomide treatment by attenuating MGMT expression. Cell death & disease 13 (12) (2022)
Florian Klemm, Aylin Möckl, Anna Salamero-Boix, Tijna Alekseeva, Alexander Schäffer, Michael Schulz, Katja Niesel, Roeltje R Maas, Marie Groth, Benelita T Elie, Robert L Bowman, Monika E Hegi, Roy T Daniel, Pia S Zeiner, Jenny Zinke, Patrick N Harter, Karl H Plate, Johanna A Joyce, Lisa Sevenich
Compensatory CSF2-driven macrophage activation promotes adaptive resistance to CSF1R inhibition in breast-to-brain metastasis. Nature cancer 2 (10) (2021)
Olga Gusyatiner, Pierre Bady, Minh D T Pham, Yvonne Lei, Jungyeon Park, Roy T Daniel, Mauro Delorenzi, Monika E Hegi
BET inhibitors repress expression of interferon-stimulated genes and synergize with HDAC inhibitors in glioblastoma. Neuro-oncology 23 (10) (2021)
Roeltje R Maas, Klara Soukup, Florian Klemm, Mara Kornete, Robert L Bowman, Romain Bedel, Damien N Marie, Angel F Álvarez-Prado, Danny Labes, Anne Wilson, Jean-Philippe Brouland, Roy T Daniel, Monika E Hegi, Johanna A Joyce
An integrated pipeline for comprehensive analysis of immune cells in human brain tumor clinical samples. Nature protocols 16 (10) (2021)
Monika E Hegi, Koichi Ichimura
MGMT testing always worth an emotion. Neuro-oncology 23 (9) (2021)
Cristina Cudalbu, Pierre Bady, Marta Lai, Lijing Xin, Olga Gusyatiner, Marie-France Hamou, Mario Lepore, Jean-Philippe Brouland, Roy T Daniel, Andreas F Hottinger, Monika E Hegi
Metabolic and transcriptomic profiles of glioblastoma invasion revealed by comparisons between patients and corresponding orthotopic xenografts in mice. Acta neuropathologica communications 9 (1) (2021)
Michael Weller, Martin J Van Den Bent, Matthias Preusser, Emilie Le Rhun, Jörg C Tonn, Giuseppe Minniti, Martin Bendszus, Carmen Balaña Quintero, Olivier Chinot, Linda Dirven, Pim J French, Monika E Hegi, Asgeir Store Jakola, Michael Platten, Patrick Roth, Roberta Rudà, Susan C Short, Marion Smits, Martin J B Taphoorn, Andreas von Deimling, Manfred Westphal, Riccardo Soffietti, Guido Reifenberger, Wolfgang Wick
EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood. Nature reviews. Clinical oncology 18 (3) (2020)
Andrew McKinney, Olle R Lindberg, Jane R Engler, Katharine Y Chen, Anupam Kumar, Henry Gong, Kan V Lu, Erin F Simonds, Timothy F Cloughesy, Linda M Liau, Michael Prados, Andrew W Bollen, Mitchel S Berger, Joseph T C Shieh, C David James, Theodore P Nicolaides, William H Yong, Albert Lai, Monika E Hegi, William A Weiss, Joanna J Phillips
Mechanisms of Resistance to EGFR Inhibition Reveal Metabolic Vulnerabilities in Human GBM. Molecular cancer therapeutics 18 (9) (2019)
Marta Lai, Irene Vassallo, Bernard Lanz, Carole Poitry-Yamate, Marie-France Hamou, Cristina Cudalbu, Rolf Gruetter, Monika E Hegi
In vivo characterization of brain metabolism by 1 H MRS, 13 C MRS and 18 FDG PET reveals significant glucose oxidation of invasively growing glioma cells. International journal of cancer 143 (1) (2018)
Pierre Bady, Sebastian Kurscheid, Mauro Delorenzi, Thierry Gorlia, Martin J van den Bent, Khê Hoang-Xuan, Élodie Vauléon, Anja Gijtenbeek, Roelien Enting, Brian Thiessen, Olivier Chinot, Frédéric Dhermain, Alba A Brandes, Jaap C Reijneveld, Christine Marosi, Martin J B Taphoorn, Wolfgang Wick, Andreas von Deimling, Pim French, Roger Stupp, Brigitta G Baumert, Monika E Hegi
The DNA methylome of DDR genes and benefit from RT or TMZ in IDH mutant low-grade glioma treated in EORTC 22033. Acta neuropathologica 135 (4) (2018)
Pratheesh Sathyan, Pascal O Zinn, Anantha L Marisetty, Bin Liu, Mohamed Mostafa Kamal, Sanjay K Singh, Pierre Bady, Li Lu, Khalida M Wani, Bethany L Veo, Joy Gumin, Dina Hamada Kassem, Frederick Robinson, Connie Weng, Veerabhadran Baladandayuthapani, Dima Suki, Howard Colman, Krishna P Bhat, Erik P Sulman, Ken Aldape, Rivka R Colen, Roel G W Verhaak, Zhimin Lu, Gregory N Fuller, Suyun Huang, Frederick F Lang, Raymond Sawaya, Monika E Hegi, Sadhan Majumder
Mir-21-Sox2 Axis Delineates Glioblastoma Subtypes with Prognostic Impact. The Journal of neuroscience : the official journal of the Society for Neuroscience 35 (45) (2016)

Monika E Hegi.css-eqlu8i{font-size:small;padding-left:4px;} (Monika Hegi)

Publication Activity (10 Years)

Top Topics

Top Venues

Monika E Hegi (Monika Hegi)